Literature DB >> 32623998

New Approaches to Develop Drug Treatment for Alzheimer's Disease: Targeting Calcium Dysregulation.

Huafeng Wei1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32623998      PMCID： PMC7720820          DOI： 10.2174/156720501704200520094610

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN： 1567-2050            Impact factor:   3.498


× No keyword cloud information.
  10 in total

1.  Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.

Authors:  Bénédicte Oulès; Dolores Del Prete; Barbara Greco; Xuexin Zhang; Inger Lauritzen; Jean Sevalle; Sebastien Moreno; Patrizia Paterlini-Bréchot; Mohamed Trebak; Frédéric Checler; Fabio Benfenati; Mounia Chami
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

Review 2.  Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease.

Authors:  Matan B Abou; Liang Sun; Huafeng Wei
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

3.  Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice.

Authors:  Jun Peng; Ge Liang; Saddet Inan; Zhen Wu; Donald J Joseph; Qingcheng Meng; Yi Peng; Maryellen F Eckenhoff; Huafeng Wei
Journal:  Neurosci Lett       Date:  2012-04-10       Impact factor: 3.046

4.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

Review 5.  Targeting Post-Translational Remodeling of Ryanodine Receptor: A New Track for Alzheimer's Disease Therapy?

Authors:  Mounia Chami; Frédéric Checler
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

Review 6.  Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer's Disease.

Authors:  Aston J Wu; Benjamin C-K Tong; Alexis S Huang; Min Li; King-Ho Cheung
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

Review 7.  The cytoprotective effects of dantrolene: a ryanodine receptor antagonist.

Authors:  Saadet Inan; Huafeng Wei
Journal:  Anesth Analg       Date:  2010-09-22       Impact factor: 6.627

8.  Intranasal administration of dantrolene increased brain concentration and duration.

Authors:  Jintao Wang; Yun Shi; Shuchun Yu; Yan Wang; Qingcheng Meng; Ge Liang; Maryellen F Eckenhoff; Huafeng Wei
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

9.  Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.

Authors:  Yun Shi; Lei Zhang; Xue Gao; Jing Zhang; Matan Ben Abou; Ge Liang; Qingcheng Meng; Adrian Hepner; Maryellen F Eckenhoff; Huafeng Wei
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease.

Authors:  Shreaya Chakroborty; Clark Briggs; Megan B Miller; Ivan Goussakov; Corinne Schneider; Joyce Kim; Jaime Wicks; Jill C Richardson; Vincent Conklin; Benjamin G Cameransi; Grace E Stutzmann
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240
  10 in total
  1 in total

Review 1.  Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.

Authors:  H-F Wei; S Anchipolovsky; R Vera; G Liang; D-M Chuang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2022-03       Impact factor: 3.784
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.